Regarding patient prognosis, a high CD8 expression level was found to be an independent poor prognostic factor in all breast cancers and was associated with shorter DFS in luminal B, ER-positive, PR-negative, HER-2-positive, and high Ki-67 L.I. breast cancer. This evidence concerns the gene MKI67 and breast cancer.